XLRN

Acceleron Pharma Inc.
XLRN

Overview Fund Activity
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

125 hedge funds and large institutions have $1.21B invested in Acceleron Pharma Inc. in 2015 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
125
Holders Change
+14
Holders Change %
+12.61%
% of All Funds
3.28%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
26
Increased
49
Reduced
32
Closed
10
Calls
$9.66M
Puts
$19.1M
Net Calls
-$9.42M
Net Calls Change
-$5.73M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$34.2M
2
SAM
2
Sectoral Asset Management
Quebec, Canada
$54.7M
3
DM
3
Deerfield Management
New York
$10.4M
4
State Street
4
State Street
Massachusetts
$25.2M
5
GIM
5
Granahan Investment Management
Massachusetts
$32M

Top Sellers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$18.9M
2
QF
2
QVT Financial
New York
$31.2M
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$143M
4
Citadel Advisors
4
Citadel Advisors
Florida
$10.8M
5
FCMI
5
Foresite Capital Management II
California
$6.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
NLVP
126
New Leaf Venture Partners
New York
– -$2.85M -114,621 Closed
PCM
127
Pentwater Capital Management
Florida
– -$2.41M -96,771 Closed
TI
128
Turner Investments
Pennsylvania
– -$1.43M -57,240 Closed
ICAP
129
Independence Capital Asset Partners
Colorado
– -$605K -24,314 Closed
GT
130
Glenmede Trust
Pennsylvania
– -$461K -18,548 Closed
SO
131
STRS Ohio
Ohio
– -$311K -12,500 Closed
QT
132
Quantbot Technologies
New York
– -$182K -7,345 Closed
PG
133
PEAK6 Group
Illinois
– -$164K -6,603 Closed
TRCT
134
Tower Research Capital (TRC)
New York
– -$22K -873 Closed
PAM
135
Panagora Asset Management
Massachusetts
– -$21K -830 Closed
2 3 4 5
6